![Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist](https://keyopinions.info/wp-content/uploads/bfi_thumb/diabetes-category-mr43xwg2nff6f4rs3c4az14zswbug82h4dcffcmrr8.jpg)
Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist
Results from the SURPASS-2 trial
Incretins are a group of metabolic hormones secreted by the gut during a meal, which convey insulinotropic signals to the pancreatic islet cells, thereby potentiating glucose-induced insulin...